The effects of these BTK inhibitors were dose dose‐dependent and occurred at pharmacological concentrations which may have clinical implications and may pave the way to the development of new antiallergic treatment concepts in patients with IgE‐dependent allergies. The gene discussed is BTK; the disease is substance dependence.